Surface plasmon resonance imaging allows the study of molecules binding in label-free and real-time conditions. The power of the technique comes from its singularities, which are multiplexing and imaging, leading to a considerable speed-up of the processes’ analyses. This will be illustrated for the study of antibody molecules by three applications, which Yannick Nizet at Synabs, and Chiraz Frydman and Karen Mercier of HORIBA reveal in this article. By experimenting with the surface plasmon resonance imaging technology via these three applications, they highlight the key advantages of this platform: sensitivity for the detection of small molecules, screening potential, and rapid experiment optimisation thanks to the label-free, real-time and multiplex capacities.

[wonderplugin_pdf src=”https://www.biopharmaceuticalmedia.com/wp-content/uploads/2019/04/Antibodies-exploration-thanks-to-label-free.pdf” width=”100%” height=”900px” style=”border:0;”]